Form 4 for FHTX Foghorn Therapeutics Inc.
Accepted 2025-04-28 00:00:00 ET · period of report 2025-04-25 · accession 0001562180-25-003257 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-04-28 | 2025-04-25 | FHTX | GOTTSCHALK ADRIAN | CEO, Dir | G - Gift | $0.00 | 0 | 511.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-25 | G | D | 300,000 | $0.00 | 511,704 | I See Footnote | — | — | (F2) Consists of 47,497 shares held by the Adrian H. Gottschalk 2023 Grantor Retained Annuity Trust dated May 26, 2023, 300,000 shares held by the Gottschalk 2025 GRAT, and 164,207 shares held by the Gottschalk Living Trust. |
| 2 | Common | Common Stock | 2025-04-25 | G | A | 300,000 | $0.00 | 511,704 | I See Footnote | — | — | (F2) Consists of 47,497 shares held by the Adrian H. Gottschalk 2023 Grantor Retained Annuity Trust dated May 26, 2023, 300,000 shares held by the Gottschalk 2025 GRAT, and 164,207 shares held by the Gottschalk Living Trust. |